Stefani Wolff is EVP and COO of Nurix Therapeutics, Inc.. Currently has a direct ownership of 6,113 shares of NRIX, which is worth approximately $121,220. The most recent transaction as insider was on May 01, 2023, when has been sold 342 shares (Common Stock) at a price of $9.88 per share, resulting in proceeds of $3,378. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.11K
0% 3M change
0% 12M change
Total Value Held $121,220

Stefani Wolff Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2023
SELL
Open market or private sale
$3,378 $9.88 p/Share
342 Reduced 5.3%
6,113 Common Stock
Apr 30 2023
BUY
Exercise of conversion of derivative security
-
962 Added 12.97%
6,455 Common Stock
Jan 30 2023
SELL
Open market or private sale
$4,994 $11.78 p/Share
424 Reduced 9.72%
3,940 Common Stock
Jan 30 2023
BUY
Exercise of conversion of derivative security
-
962 Added 18.06%
4,364 Common Stock
Oct 31 2022
SELL
Open market or private sale
$4,508 $12.88 p/Share
350 Reduced 9.33%
3,402 Common Stock
Oct 30 2022
BUY
Exercise of conversion of derivative security
-
962 Added 20.41%
3,752 Common Stock
Aug 01 2022
SELL
Open market or private sale
$5,579 $15.67 p/Share
356 Reduced 22.33%
1,238 Common Stock
Jul 30 2022
BUY
Exercise of conversion of derivative security
-
962 Added 37.64%
1,594 Common Stock
May 02 2022
SELL
Open market or private sale
$3,878 $11.75 p/Share
330 Reduced 34.3%
632 Common Stock
Apr 30 2022
BUY
Exercise of conversion of derivative security
-
962 Added 50.0%
962 Common Stock

Also insider at

RAIN
Rain Therapeutics Inc. Healthcare
SW

Stefani Wolff

EVP and COO
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Track Activities on NRIX